New Guidance Published on Biologics Use in Psoriasis, PsA
Recently released guidelines from Japan outline the factors that may influence the choice of biologic agents for treatment in patients with psoriasis.
Psoriasis
Similar Rates of Depression and Anxiety Plus Depression With Apremilast vs Other Drugs in Psoriatic Arthritis
Apremilast used for the treatment of psoriasis or psoriatic arthritis is not associated with a high risk of incident treated depression, anxiety, or anxiety plus depression.
End-Stage Renal Disease Linked to Psoriasis, Psoriatic Arthritis
Patients with psoriasis showed an increased risk for ESRD development although patients who received systemic anti-psoriasis agents did not, a nationwide cohort study reveals.
TNFi Therapy Associated With Higher Risk for Serious Infections in Self-Reported PsA
Researchers evaluated the risk for adverse events, including serious infections, among patients with self-reported psoriatic arthritis compared with those with psoriasis.
Low Incidence of Adverse Events With IL-17, IL-23 Inhibitors in Psoriasis, Psoriatic Arthritis
IL-17 and IL-23 inhibitors appear to be well tolerated, with good safety profiles; recent findings outlined here may aid clinical decision making when choosing the most appropriate therapy for patients with moderate to severe psoriasis.
Case Highlights Novel Approach to Treatment of Ulcerative Colitis, Psoriatic Arthritis
A recently published report presented at the 2019 AIBD Annual Meeting in Orlando, FL, discussed the case of a patient who developed ulcerative colitis (UC) following treatment with Secukinumab for her psoriatic arthritis and highlighted a novel approach for the management of both of her conditions simultaneously.
Methotrexate Injection Approved for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriasis Treatment
The FDA has approved RediTrex (methotrexate injection; Cumberland) for the management of patients with severe, active rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis, who are intolerant of or had an inadequate response to first-line therapy.
Psoriatic Arthritis Risk Associated With Ultrasound Evidence of Arthralgia
Using ultrasound, researchers evaluated the anatomic basis for arthralgia in patients with psoriasis; they also explored the rate of psoriatic arthritis development in patients with psoriasis with and without arthralgia.
Disease Activity, Functional Impairment in Axial Spondyloarthritis With Psoriasis or Inflammatory Bowel Disease
Researchers assessed the effect of uveitis, psoriasis, and inflammatory bowel disease on disease activity and functional status in a population-based cohort of patients with axial spondyloarthritis.
Biomarkers of Peripheral and Axial Arthritis in Psoriatic Disease
Study confirms the validity of previously identified bone-turnover biomarkers for psoriatic disease-associated arthritis and for axial arthritis.
Next post in Spondyloarthritis
